Future Capital invests in companies engaged in the life sciences and chemistry, including nanotechnology and material sciences.
Business Model:
Revenue: $0
Employees: 0-0
Address: Beethovenstrasse 5
City: Frankfurt
State: hesse
Zip: 60325
Country: DE
Future Capital invests in companies engaged in the life sciences and chemistry, including nanotechnology and material sciences. The fund was founded in March 1999 at the initiative of the Hessen State Government and Hoechst AG (now Sanofi Group) and acts as an independent venture. Future Capital AG manages assets of € 51 million and invests € 0.75 to 10 million per company.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2007 | Ganymed Pharmaceuticals | Series C | 47.5M |
1/2016 | Nongfenqi | Series A | - |
7/2005 | Ganymed Pharmaceuticals | Series B | 14.4M |
12/2019 | ClickPaaS China | Series A | - |
3/2018 | Li Auto | Series B | 0 |
11/2013 | Ganymed Pharmaceuticals | Series E | 0 |
10/2020 | Bishi Technology | Series B | 22.3M |
11/2008 | Ganymed Pharmaceuticals | Series D | 81.8M |
5/2021 | MegaRobo | Corporate Round | 0 |
4/2000 | 3-G International | Private Equity Round | 0 |
4/2016 | Yihang.ai | Angel Round | - |
3/2017 | Missevan | Series A | - |
8/2020 | Aignostics | Seed Round | 6M |
9/2019 | Ruixun Biotech | Series A | - |
5/2021 | MegaRobo | Corporate Round | 0 |
10/2020 | Bishi Technology | Series B | 0 |
8/2020 | Aignostics | Seed Round | 0 |
12/2019 | ClickPaaS China | Series A | - |
9/2019 | Ruixun Biotech | Series A | - |
3/2018 | Li Auto | Series B | 0 |
3/2017 | Missevan | Series A | - |
4/2016 | Yihang.ai | Angel Round | - |
1/2016 | Nongfenqi | Series A | - |
11/2013 | Ganymed Pharmaceuticals | Series E | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|